ALKBH5 and metabolic dysfunction-associated steatotic liver disease: In the mouse model of non-alcoholic fatty liver disease (NAFLD), inhibiting the activity of ALKBH5 significantly induced hepatocytes autophagy by reducing the stability of AXL mRNA (Meng et al., 2023).